ArticleNeuro-oncology2014
Radiotherapy versus observation following surgical resection of atypical meningioma (the ROAM trial).
Abstract readLetterComment
In one paragraph
Article in Neuro-oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Multidisciplinary management of meningiomas in the era of precision oncology.Nature reviews. Clinical oncology · 2026Review
- Multidisciplinary treatment strategy optimization and long-term prognosis in spheno-orbital meningiomas: a multicenter retrospective study.Neurosurgical review · 2026Article
- Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma.Nature medicine · 2024Article
- Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.Neuro-oncology · 2024Review
- [A 34-gene expression biomarker to predict oncologic outcome and treatment response after radiotherapy in meningioma].Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024Article
- Radiotherapy intensification for atypical and malignant meningiomas: A systematic review.Neuro-oncology practice · 2024Review
- Outcomes and predictors of response to fractionated radiotherapy as primary treatment for intracranial meningiomas.Clinical and translational radiation oncology · 2023Article
- Article
- DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case-Control Study.Frontiers in oncology · 2022Article
- Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas.CNS oncology · 2021Review
- Differentially Expressed MicroRNAs in Radioresistant and Radiosensitive Atypical Meningioma: A Clinical Study in Chinese Patients.Frontiers in oncology · 2020Article
- An overview of meningiomas.Future oncology (London, England) · 2018Review
- Does Proton Therapy Have a Future in CNS Tumors?Current treatment options in neurology · 2017Review
- WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment.Journal of neuro-oncology · 2016Article
- Article
- Proton therapy for atypical meningiomas.Journal of neuro-oncology · 2015Article
- An analysis of prognostic factors associated with recurrence in the treatment of atypical meningiomas.Advances in radiation oncologyArticle
Corrections and comments
- Comment on
Authors and funding
6 authors.
Michael D JenkinsonDepartment of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK (M.D.J., R.Z.); Institute of Infection and Global Health, University of Liverpool, Liverpool, UK (M.D.J., C.L.M.); Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland (D.C.W.); University of Bern, Bern, Switzerland (D.C.W.); Department of Radiation Oncology, Clatterbridge Cancer Centre, Wirral, UK (B.J.H.); Department of Paediatric Neurosurgery, Alder Hey Children's Hospital, Liverpool, UK (C.L.M.); Department of Neurosurgery, Beaumont Hospital, Dublin, Ireland (M.J.).
Damien C WeberDepartment of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK (M.D.J., R.Z.); Institute of Infection and Global Health, University of Liverpool, Liverpool, UK (M.D.J., C.L.M.); Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland (D.C.W.); University of Bern, Bern, Switzerland (D.C.W.); Department of Radiation Oncology, Clatterbridge Cancer Centre, Wirral, UK (B.J.H.); Department of Paediatric Neurosurgery, Alder Hey Children's Hospital, Liverpool, UK (C.L.M.); Department of Neurosurgery, Beaumont Hospital, Dublin, Ireland (M.J.).
Brian J HaylockDepartment of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK (M.D.J., R.Z.); Institute of Infection and Global Health, University of Liverpool, Liverpool, UK (M.D.J., C.L.M.); Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland (D.C.W.); University of Bern, Bern, Switzerland (D.C.W.); Department of Radiation Oncology, Clatterbridge Cancer Centre, Wirral, UK (B.J.H.); Department of Paediatric Neurosurgery, Alder Hey Children's Hospital, Liverpool, UK (C.L.M.); Department of Neurosurgery, Beaumont Hospital, Dublin, Ireland (M.J.).
Conor L MallucciDepartment of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK (M.D.J., R.Z.); Institute of Infection and Global Health, University of Liverpool, Liverpool, UK (M.D.J., C.L.M.); Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland (D.C.W.); University of Bern, Bern, Switzerland (D.C.W.); Department of Radiation Oncology, Clatterbridge Cancer Centre, Wirral, UK (B.J.H.); Department of Paediatric Neurosurgery, Alder Hey Children's Hospital, Liverpool, UK (C.L.M.); Department of Neurosurgery, Beaumont Hospital, Dublin, Ireland (M.J.).
Rasheed ZakariaDepartment of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK (M.D.J., R.Z.); Institute of Infection and Global Health, University of Liverpool, Liverpool, UK (M.D.J., C.L.M.); Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland (D.C.W.); University of Bern, Bern, Switzerland (D.C.W.); Department of Radiation Oncology, Clatterbridge Cancer Centre, Wirral, UK (B.J.H.); Department of Paediatric Neurosurgery, Alder Hey Children's Hospital, Liverpool, UK (C.L.M.); Department of Neurosurgery, Beaumont Hospital, Dublin, Ireland (M.J.).
Mohsen JavadpourDepartment of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK (M.D.J., R.Z.); Institute of Infection and Global Health, University of Liverpool, Liverpool, UK (M.D.J., C.L.M.); Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland (D.C.W.); University of Bern, Bern, Switzerland (D.C.W.); Department of Radiation Oncology, Clatterbridge Cancer Centre, Wirral, UK (B.J.H.); Department of Paediatric Neurosurgery, Alder Hey Children's Hospital, Liverpool, UK (C.L.M.); Department of Neurosurgery, Beaumont Hospital, Dublin, Ireland (M.J.).
Funding
Department of Health HTA/12/173/14
Abstract
PubMed holds no abstract for this paper.
Indexed as
HumansMeningeal NeoplasmsMeningioma
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.